Thompson Siegel & Walmsley LLC Abbott Laboratories Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 3,395 shares of ABT stock, worth $434,322. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,395

Previous 2,878 17.96%

Holding current value

$434,322

Previous $299,000 29.43%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $51,736 - $61,073	517 Added 17.96%	3,395 $387,000
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $2,705 - $3,312	-30 Reduced 1.03%	2,878 $317,000
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $12,698 - $14,148	-126 Reduced 4.15%	2,908 $317,000
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $4,649 - $5,472	-48 Reduced 1.56%	3,034 $307,000
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $30,038 - $35,240	316 Added 11.42%	3,082 $338,000
Q3 2022 Dec 15, 2022	BUY	$96.76 - $112.03 $267,638 - $309,874	2,766 New	2,766 $268,000
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $320,908 - $387,875	-3,144 Reduced 53.2%	2,766 $301,000
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $4,043 - $4,951	-35 Reduced 0.59%	5,910 $832,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $11,082 - $12,260	-95 Reduced 1.57%	5,945 $702,000
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $6,876 - $8,094	-65 Reduced 1.06%	6,040 $700,000
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $56,814 - $66,936	522 Added 9.35%	6,105 $732,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 1.76%	5,583 $608,000
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $7,656 - $9,800	-100 Reduced 1.73%	5,683 $520,000
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $11,244 - $16,442	-179 Reduced 3.0%	5,783 $456,000
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $71,522 - $79,621	-911 Reduced 13.25%	5,962 $518,000
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $75,947 - $82,350	-928 Reduced 11.9%	6,873 $575,000
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $53,056 - $61,880	728 Added 10.29%	7,801 $656,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $10,330 - $12,489	156 Added 2.26%	7,073 $565,000
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $26,513 - $31,984	-436 Reduced 5.93%	6,917 $507,000
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $30,857 - $34,057	536 Added 7.86%	7,353 $448,000
Q1 2018 May 08, 2018	SELL	$56.27 - $63.62 $16,881 - $19,086	-300 Reduced 4.22%	6,817 $408,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $120,780 - $129,307	2,250 Added 46.23%	7,117 $406,000
Q2 2017 Aug 09, 2017	BUY	N/A	4,867	4,867 $237,000

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Abbott Laboratories Transaction History